经静脉途径应用Eval胶联合弹簧圈栓塞治疗海绵窦区硬脑膜动静脉瘘

目的 探讨经静脉入路应用Eval胶联合弹簧圈栓塞治疗海绵窦区硬脑膜动静脉瘘（CS-DAVF）的安全性和有效性。方法 回顾性分析2015年1月至2020年10月收治的17例CS-DAVF的临床资料。所有病人均经静脉入路应用Eval胶联合弹簧圈栓塞治疗。结果 术后即刻DSA显示，17例CS-DAVF均完全栓塞。术后早期出现治疗相关并发症5 例（29.41%），其中头痛2例，动眼神经麻痹2例，外展神经麻痹1 例。术后随访3~24个月，平均7.3个月；改良Rankin量表评分0分16 例，1分1例（遗留动眼神经麻痹）。结论 经静脉入路使用Eval胶联合弹簧圈栓塞治疗CS-DAVF，效果良好，治愈率高，并发症少。

Transvenous embolization using Eval glue and coil for patients with cavernous dural arteriovenous fistula

Objective To explore the safety and efficacy of transvenous embolization (TVE) using Eval glue and coil for the patients with cavernous sinus dural arteriovenous fistula (CS-DAVF). Methods The clinical data of 17 patients with CS-DAVF who received TVE using Eval glue and coil from January 2015 to October 2020 were retrospectively analyzed. Results Immediate postoperative DSA results indicated that the fistulas were completely embolized in all the patients. Treatment-related complications occurred in 5 patients (29.41%), of whom 2 patients suffered from headache, 2 oculomotor nerve palsy and 1 abducents nerve palsy. The follow-up (range, 3~24 months; mean, 7.3 months) outcomes showed mRS score of 0 in 16 patients and mRS score of 1 in 1 who suffered from the continuous existence of oculomotor nerve palsy. Conclusions TVE using Eval glue combined with coil for the patients with CS-DAVF has good outcomes, which can improve the cure rate of CS-DAVF and reduce the incidence of complications.